Existing users please login

 

Home / Markets

Early-Market Movers:  Akamai, Motorola

 
By Michael Goldstein
FOXBusiness
     

    Stock futures were moving higher indicating a strong open after a 3.5% jump in gross domestic products in the third quarter and a drop in jobless claims.

    Here are some of the early-market movers for Thursday.

     Akamai Technologies Inc. (AKAM)

    Shares were up 7.9% in pre-market trading Thursday after third-quarter results were released after the bell Wednesday, which beat analyst expectations. Earnings, excluding items, were reported at 25 cents per share on revenue of $206.5 million. Analysts had estimated earnings of 35 cents per share on $199.4 million in revenue.

     American Superconductor Corp (AMSC)

    The company released second-quarter results beating analyst estimates reporting earnings of 19 cents per share and revenue of %74.74 million. Analysts had been expecting earnings of 13 cents per share and revenue of $69 million. Quarterly revenue was up 85% and the company raised guidance for the remainder of the fiscal year. Shares were up 14% in pre-market trading.

    Lemaitre Vascular Inc. (LMAT)

    Shares of the medical device manufacturer were up 9.9% in pre-market trading after the company posted third-quarter results which beat analyst expectations. The company reported earnings of 8 cents per share on revenue of $13.3 million. Analysts had been expecting earnings of 1 cent per share on revenue of $11.8 million.

     Motorola Inc. (MOT)

    The company swung to a third-quarter profit reporting earnings of 1 cent per share on revenue of $5.45 billion. Analysts had been expecting the company to break even on revenue of %5.54 billion. Shares were up 7% in pre-market trading on the positive earnings which come ahead of the release of two new smart phones aimed at driving the company’s momentum.

     Transcept Pharmaceuticals (TSPT)

    Shares dropped 45.5% in pre-market trading after the company announced the FDA did not approve its new drug application for sleep disorder drug Intermezzo and requested additional data based on safety concerns.

    First Solar Inc. (FSLR)

    Despite a 54% rise in profit, First Solar shares were down 12.1% in pre-market trading after posting a revenue miss for the third quarter on a drop in gross margins. Earnings came in at $1.79 per share beating analyst estimates of $1.74, but $480.9 million in revenue came in below expectations of $529 million.

     

     

    Fox Business Video